Volume 120, Issue 5 , Pages 1153-1159, November 2007
Patients with asthma who do not fill their inhaled corticosteroids: A study of primary nonadherence
Background
Adherence to inhaled corticosteroids (ICSs) is known to be poor among patients with asthma; however, little is known about patients who do not fill their ICS prescriptions (ie, primary nonadherence).
Objective
To estimate rates of primary nonadherence and to explore associated factors.
Methods
The study population was members of a large health maintenance organization in southeast Michigan who met the following criteria: age 5 to 56 years; previous diagnosis of asthma; at least 1 electronic prescription for an ICS between February 17, 2005, and June 1, 2006; and at least 3 months follow-up after the ICS prescription. Adherence was estimated by using electronic prescription information and pharmacy claims data. Multivariable stepwise analysis was used to identify factors associated with primary nonadherence compared with adherent patients.
Results
One thousand sixty-four patients met the study criteria and had calculable adherence. Of these patients, 82 (8%) never filled their ICS prescription. Stepwise regression identified the following factors to be associated with an increased likelihood of primary nonadherence: younger age, female sex, African American race-ethnicity, and lower rescue medication use. Factors associated with primary nonadherence differed between race-ethnic groups.
Conclusion
Primary nonadherence was associated with lower baseline rescue medication use, which may reflect lower perceived need for ICS therapy in patients with milder asthma. Rates of primary nonadherence and the factors which influenced this outcome differed by race-ethnicity.
Clinical implications
Understanding patient characteristics associated with primary nonadherence may be important for disease management, because many patients with asthma do not fill their ICS prescriptions.
Key words: Primary nonadherence, inhaled corticosteroids, asthma, race-ethnicity, controller medication
Abbreviations used: CMA, Continuous, multiple-interval measure of medication availability, ICS, Inhaled corticosteroid, OR, Odds ratio
Supported by a grant from the National Heart Lung and Blood Institute, National Institutes of Health (R01HL079055), and the Fund for Henry Ford Hospital.
Disclosure of potential conflict of interest: L. K. Williams has received grant support from the National Institute of Allergy and Infectious Diseases and the National Heart, Lung, and Blood Institute, National Institutes of Health. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(07)01586-2
doi:10.1016/j.jaci.2007.08.020
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 120, Issue 5 , Pages 1153-1159, November 2007
